276 related articles for article (PubMed ID: 15280205)
1. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation.
Alpdogan O; Eng JM; Muriglan SJ; Willis LM; Hubbard VM; Tjoe KH; Terwey TH; Kochman A; van den Brink MR
Blood; 2005 Jan; 105(2):865-73. PubMed ID: 15280205
[TBL] [Abstract][Full Text] [Related]
2. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.
Alpdogan O; Schmaltz C; Muriglan SJ; Kappel BJ; Perales MA; Rotolo JA; Halm JA; Rich BE; van den Brink MR
Blood; 2001 Oct; 98(7):2256-65. PubMed ID: 11568014
[TBL] [Abstract][Full Text] [Related]
3. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
4. Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation.
Alpdogan SO; Lu SX; Patel N; McGoldrick S; Suh D; Budak-Alpdogan T; Smith OM; Grubin J; King C; Goldberg GL; Hubbard VM; Kochman AA; van den Brink MR
Blood; 2008 Dec; 112(12):4755-64. PubMed ID: 18815289
[TBL] [Abstract][Full Text] [Related]
5. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
6. GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.
Bunting MD; Varelias A; Souza-Fonseca-Guimaraes F; Schuster IS; Lineburg KE; Kuns RD; Fleming P; Locke KR; Huntington ND; Blazar BR; Lane SW; Tey SK; MacDonald KP; Smyth MJ; Degli-Esposti MA; Hill GR
Blood; 2017 Feb; 129(5):630-642. PubMed ID: 27927647
[TBL] [Abstract][Full Text] [Related]
7. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
8. Donor NK Cells and IL-15 promoted engraftment in nonmyeloablative allogeneic bone marrow transplantation.
Hu B; Bao G; Zhang Y; Lin D; Wu Y; Wu D; Liu H
J Immunol; 2012 Aug; 189(4):1661-70. PubMed ID: 22798668
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT.
Sauter CT; Bailey CP; Panis MM; Biswas CS; Budak-Alpdogan T; Durham A; Flomenberg N; Alpdogan O
Bone Marrow Transplant; 2013 Sep; 48(9):1237-42. PubMed ID: 23624821
[TBL] [Abstract][Full Text] [Related]
10. Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells.
Satake A; Inoue T; Kubo S; Taniguchi Y; Imado T; Fujioka T; Horiuchi M; Xu Y; Ikegame K; Yoshihara S; Kaida K; Tamaki H; Okada M; Okamura H; Ogawa H
Int J Hematol; 2010 Apr; 91(3):485-97. PubMed ID: 20300982
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.
Yang YG; Sergio JJ; Pearson DA; Szot GL; Shimizu A; Sykes M
Blood; 1997 Dec; 90(11):4651-60. PubMed ID: 9373279
[TBL] [Abstract][Full Text] [Related]
12. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
Min CK; Maeda Y; Lowler K; Liu C; Clouthier S; Lofthus D; Weisiger E; Ferrara JL; Reddy P
Blood; 2004 Nov; 104(10):3393-9. PubMed ID: 15280194
[TBL] [Abstract][Full Text] [Related]
14. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.
Jenq RR; King CG; Volk C; Suh D; Smith OM; Rao UK; Yim NL; Holland AM; Lu SX; Zakrzewski JL; Goldberg GL; Diab A; Alpdogan O; Penack O; Na IK; Kappel LW; Wolchok JD; Houghton AN; Perales MA; van den Brink MR
Blood; 2009 Feb; 113(7):1574-80. PubMed ID: 19011222
[TBL] [Abstract][Full Text] [Related]
15. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation.
Alpdogan O; Muriglan SJ; Kappel BJ; Doubrovina E; Schmaltz C; Schiro R; Eng JM; Greenberg AS; Willis LM; Rotolo JA; O'Reilly RJ; van den Brink MR
Transplantation; 2003 Jun; 75(12):1977-83. PubMed ID: 12829897
[TBL] [Abstract][Full Text] [Related]
17. Expression of HLA-C-specific natural killer cell receptors (CD158a and CD158b) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
Tanaka J; Mori A; Ohta S; Yamamoto Y; Kobayashi S; Hashino S; Kobayashi M; Asaka M; Imamura M
Br J Haematol; 2000 Mar; 108(4):778-83. PubMed ID: 10792283
[TBL] [Abstract][Full Text] [Related]
18. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
[TBL] [Abstract][Full Text] [Related]
19. Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease.
Blaser BW; Roychowdhury S; Kim DJ; Schwind NR; Bhatt D; Yuan W; Kusewitt DF; Ferketich AK; Caligiuri MA; Guimond M
Blood; 2005 Jan; 105(2):894-901. PubMed ID: 15374888
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation.
Imado T; Iwasaki T; Kataoka Y; Kuroiwa T; Hara H; Fujimoto J; Sano H
Blood; 2004 Sep; 104(5):1542-9. PubMed ID: 15100150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]